O-009 Long ncRNA Landscape in the Ileum of Treatment Naive Early Onset Crohn Disease.

Haberman, Yael; Ben-Shoshan, Marina; Di-Segni, Ayelet; More

Inflammatory Bowel Diseases . 23():S3-S4, February 2017.

Real‐time tool to display the predicted disease course and treatment response for children with Crohn's disease

Siegel, Corey A.; Siegel, Lori S.; Hyams, Jeffrey S.; More

Inflammatory Bowel Diseases . 17(1):30-38, January 2011.

Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: A case series

Dotson, Jennifer L.; Crandall, Wallace; Mousa, Hayat; More

Inflammatory Bowel Diseases . 17(1):56-61, January 2011.

ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network

Crandall, Wallace; Kappelman, Michael D.; Colletti, Richard B.; More

Inflammatory Bowel Diseases . 17(1):450-457, January 2011.

Appraisal of the pediatric ulcerative colitis activity index (PUCAI)

Turner, Dan; Hyams, Jeffrey; Markowitz, James; More

Inflammatory Bowel Diseases . 15(8):1218-1223, August 2009.

Long‐term outcome of maintenance infliximab therapy in children with Crohn's disease

Hyams, Jeffrey S.; Lerer, Trudy; Griffiths, Anne; More

Inflammatory Bowel Diseases . 15(6):816-822, June 2009.

Age of diagnosis influences serologic responses in children with Crohn's disease: A possible clue to etiology?

Markowitz, James; Kugathasan, Subra; Dubinsky, Marla; More

Inflammatory Bowel Diseases . 15(5):714-719, May 2009.

Course and Treatment of Perianal Disease in Children Newly Diagnosed with Crohn's Disease

Keljo, David J.; Markowitz, James; Langton, Christine; More

Inflammatory Bowel Diseases . 15(3):383-387, March 2009.

Effect of early immunomodulator use in moderate to severe pediatric Crohn disease

Punati, Jaya; Markowitz, James; Lerer, Trudy; More

Inflammatory Bowel Diseases . 14(7):949-954, July 2008.